Sorafenib suppresses growth and survival of hepatoma cells by accelerating degradation of enhancer of zeste homolog 2

Enhancer of zeste homolog 2 (EZH2) is a mammalian histone methyltransferase that contributes to the epigenetic silencing of target genes that regulate cancer cell growth and survival. It is overexpressed in hepatocellular carcinoma (HCC) with a clinical significance that remains obscure. Sorafenib,...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Sci
Main Authors: Wang, Shanshan, Zhu, Yu, He, Hongyong, Liu, Jing, Xu, Le, Zhang, Heng, Liu, Haiou, Liu, Weisi, Liu, Yidong, Pan, Deng, Chen, Lin, Wu, Qian, Xu, Jiejie, Gu, Jianxin
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2013
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7657235/
https://ncbi.nlm.nih.gov/pubmed/23421437
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12132
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares